Swedish Orphan Biovitrum AB (publ) (FRA:B6E)

FRA:B6E Statistics

Total Valuation

FRA:B6E has a market cap or net worth of EUR 10.71 billion. The enterprise value is 11.85 billion.

Market Cap	10.71B
Enterprise Value	11.85B

Important Dates

The next estimated earnings date is Thursday, February 5, 2026.

Earnings Date	Feb 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	344.66M
Shares Outstanding	n/a
Shares Change (YoY)	-1.02%
Shares Change (QoQ)	-0.73%
Owned by Insiders (%)	0.30%
Owned by Institutions (%)	48.19%
Float	220.73M

Valuation Ratios

The trailing PE ratio is 9,105.25 and the forward PE ratio is 18.71.

PE Ratio	9,105.25
Forward PE	18.71
PS Ratio	4.25
PB Ratio	3.29
P/TBV Ratio	n/a
P/FCF Ratio	16.14
P/OCF Ratio	16.04
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.15, with an EV/FCF ratio of 17.86.

EV / Earnings	10,078.01
EV / Sales	4.67
EV / EBITDA	12.15
EV / EBIT	18.23
EV / FCF	17.86

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.38.

Current Ratio	1.02
Quick Ratio	0.69
Debt / Equity	0.38
Debt / EBITDA	1.27
Debt / FCF	1.85
Interest Coverage	8.01

Financial Efficiency

Return on equity (ROE) is 0.01% and return on invested capital (ROIC) is 8.53%.

Return on Equity (ROE)	0.01%
Return on Assets (ROA)	6.41%
Return on Invested Capital (ROIC)	8.53%
Return on Capital Employed (ROCE)	13.47%
Revenue Per Employee	1.33M
Profits Per Employee	622
Employee Count	1,806
Asset Turnover	0.40
Inventory Turnover	1.41

Taxes

Income Tax	-63.77M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.28% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+16.28%
50-Day Moving Average	28.75
200-Day Moving Average	26.65
Relative Strength Index (RSI)	57.80
Average Volume (20 Days)	30

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:B6E had revenue of EUR 2.52 billion and earned 1.18 million in profits. Earnings per share was 0.00.

Revenue	2.52B
Gross Profit	1.97B
Operating Income	645.37M
Pretax Income	-63.32M
Net Income	1.18M
EBITDA	956.70M
EBIT	645.37M
Earnings Per Share (EPS)	0.00

Balance Sheet

The company has 93.98 million in cash and 1.23 billion in debt, giving a net cash position of -1.14 billion.

Cash & Cash Equivalents	93.98M
Total Debt	1.23B
Net Cash	-1.14B
Net Cash Per Share	n/a
Equity (Book Value)	3.25B
Book Value Per Share	9.44
Working Capital	22.88M

Cash Flow

In the last 12 months, operating cash flow was 667.62 million and capital expenditures -4.25 million, giving a free cash flow of 663.37 million.

Operating Cash Flow	667.62M
Capital Expenditures	-4.25M
Free Cash Flow	663.37M
FCF Per Share	n/a

Margins

Gross margin is 78.16%, with operating and profit margins of 25.62% and 0.05%.

Gross Margin	78.16%
Operating Margin	25.62%
Pretax Margin	-2.51%
Profit Margin	0.05%
EBITDA Margin	37.98%
EBIT Margin	25.62%
FCF Margin	26.33%

Dividends & Yields

FRA:B6E does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.02%
Shareholder Yield	1.02%
Earnings Yield	0.01%
FCF Yield	6.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:B6E has an Altman Z-Score of 3.21 and a Piotroski F-Score of 7.

Altman Z-Score	3.21
Piotroski F-Score	7